## AMP: Ameriprise Financial, Inc. - XLF: Financial Services

### Executive Summary

No thesis match: MRS_20 -0.8% below STRENGTH zone (4.0-10.0%); PEG 1.69 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($433.37)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Advisor Joins Ameriprise Financial With $110 Million In Assets for Financial Planning Culture and Growth Opportunities**
- Source: Business Wire | 20251201T063704 | Bullish | Relevance: 100%
- Financial advisor Mike Felton, CFP®, has joined Ameriprise Financial from Merrill Lynch, bringing $110 million in client assets. Felton chose Ameriprise for its comprehensive financial planning culture, integrated support model, and advanced technology, aiming for greater control over his practice and enhanced client relationships. This move highlights Ameriprise's continued success in attracting experienced advisors.

**2. Advisory M&A News – 12/1/2025**
- Source: planadviser | 20251201T120304 | Somewhat-Bullish | Relevance: 99%
- This article details several significant M&A activities and advisory team movements in the financial sector as of December 1, 2025. Key events include a Wells Fargo adviser team joining Ameriprise Financial, two Chicago advisers moving to Cetera Financial, Cetera acquiring two former LPL advisers, and Merit Financial Advisors expanding its presence through the acquisition of Blueprint Wealth Advisors. These transactions highlight strategic growth and restructuring within the wealth management and advisory industry.

**3. Is the Addition of Harpland Financial Influencing Ameriprise's Adviser Growth Strategy (AMP)?**
- Source: Sahm | 20251130T181500 | Somewhat-Bullish | Relevance: 97%
-  Harpland Financial Management joined Ameriprise Financial, bringing over US$160 million in client assets and highlighting Ameriprise's focus on expanding its adviser network through technology and integrated tools. This move supports Ameriprise's growth strategy centered on recruitment, retention, and adviser productivity, although competition for talent poses a potential risk to margins. Ameriprise projects significant revenue and earnings growth by 2028, with current fair value estimates suggesting an upside.

**4. Jefferies Financial Group Inc. Sells 21,687 Shares of Zimmer Biomet Holdings, Inc. $ZBH**
- Source: MarketBeat | 20251129T105454 | Somewhat-Bullish | Relevance: 72%
- Jefferies Financial Group Inc. significantly reduced its stake in Zimmer Biomet Holdings, Inc. by selling 21,687 shares, retaining 6,800 shares worth $620,000. This comes as other large institutional investors like Ameriprise and JPMorgan Chase & Co. have substantially increased their positions, while Zimmer Biomet reported Q3 earnings that beat estimates but revenue slightly missed, with FY2025 guidance set. Analyst ratings for ZBH are mixed, with a consensus "Hold" rating and an average target price of $109.00.

**5. 8,761,686 Shares in Applied Materials, Inc. $AMAT Acquired by Norges Bank**
- Source: MarketBeat | 20251129T115118 | Neutral | Relevance: 66%
- Norges Bank acquired a significant new stake of 8,761,686 shares in Applied Materials, Inc. (NASDAQ:AMAT) during the second quarter, valued at approximately $1.604 billion, representing about 1.09% of the company. This acquisition follows Applied Materials' recent strong quarterly earnings, beating EPS estimates, and a declared quarterly dividend of $0.46. The company currently holds a "Moderate Buy" consensus rating from analysts, with a target price of $228.04.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-13 | Argus Research | $554 | $568 | -2% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-13 | Argus Research | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($0.05M) |
| Sells | 1 ($0.68M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- Vanguard Group Inc: 13.3% (-0.5%)
- JPMORGAN CHASE & CO: 10.3% (+53.2%)
- Blackrock Inc.: 9.7% (-5.2%)
- State Street Corpora: 4.8% (+0.4%)
- Geode Capital Manage: 3.1% (+0.8%)

### Key Risks

1. Long-term trend broken: trading 8.4% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.69 elevated, pricing in significant growth expectations. Quality metrics strong (ROE 60%, margin 20%). Balance sheet: strong liquidity (308.1x), $2.2B free cash flow. Analyst sentiment negative (1 target cuts vs 0 raises). Institutional flow bullish (4 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $46.9B |
| Beta | 1.26 |
| 52W Range | $396.14 - $582.05 |
| Short Interest | 3.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.69 |
| Forward P/E | 11.0 |
| Current P/E | 11.8 |
| YoY Growth | 7.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 stable at -0.8% (minimal 5-day change). Below STRENGTH zone by 4.8pp (needs >4.0% for momentum thesis). Below SMA200 (0.92x), long-term trend not supportive. MACD histogram positive (1.53), confirming momentum. RSI neutral at 46.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.76% (CS: 42) | Neutral |
| RSI_14 | 46.5 | Neutral |
| MACD Histogram | 1.53 | Bullish |
| vs SMA20 | 1.002x | Above |
| vs SMA50 | 0.964x | Below |
| vs SMA200 | 0.916x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $454.91
- **Stop Loss:** $433.37 (4.7% risk)
- **Target:** $476.45 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 46
- **Position Value:** $20,925.86
- **Portfolio %:** 20.93%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

### Earnings

**Next:** 2026-01-28 (Est: $10.23)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $9.76 | $9.87 | +1.1% |
| 2025Q2 | $9.00 | $9.11 | +1.2% |
| 2025Q1 | $9.08 | $9.50 | +4.6% |
| 2024Q4 | $9.05 | $9.36 | +3.5% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*